Interpretation of the guidance of stability testing of drug substances and products
10.13699/j.cnki.1001-6821.2014.10.031
- VernacularTitle:解读《化学药物(原料药和制剂)稳定性研究技术指导原则》
- Author:
Xiu-Min HUO
1
;
Nong-Nong WEI
;
Wu HE
;
Yu-Nan MA
Author Information
1. 国家食品药品监督管理总局 药品审评中心
- Keywords:
drug substance;
drug product;
stability;
guidance
- From:
The Chinese Journal of Clinical Pharmacology
2014;(10):974-978
- CountryChina
- Language:Chinese
-
Abstract:
The guidance of stability testing of drug substances and prod -ucts has been revised based on the previous version published by the State Food and Drug Administration [SFDA, now called China Food and Drug Administration(CFDA)] in 2005.This article will interpret the un-derlying principles and background information behind the guidance revi -sion, demonstrate the cognition and major revision points , clarify appli-cation -related concepts, and deeply elucidate the issues raised on drug stability research.This shall help drug developers and manufacturers to have better understanding of the guidance and shall serve as a reference for subsequent experimental designing and application document writing of drug stability tests.